Genentech to shut down cancer immunology research department amid broader R&D rethink.

Authors :: Liu, Angus
Source :: FierceBiotech; 8/16/2024, pN.PAG-N.PAG, 1p
Publication Year :: 2024
Abstract: Cell biologist Ira Mellman, who has been with Genentech for 17 years and is credited for the introduction of Tecentriq, will leave the company. [ABSTRACT FROM AUTHOR]

Subjects :: RESEARCH departments
ATEZOLIZUMAB
CANCER research
LAYOFFS
IMMUNOTHERAPY

Tools